[ATRA] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ATRA] Atara Biotherapeutics, Inc.
Announcement Date
01-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 1.84%
YoY- 17.00%
Quarter Report
ATRA's Result
ATRA's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 40,190 2,138 4,459 5,370 0 0 0 -
PBT -21,926 -69,816 -84,081 -84,664 -74,342 -71,895 -58,361 -15.04%
Tax -17 -19 10 -541 6 0 0 -
NP -21,909 -697,970 -840,910 -846,640 -743,480 -718,950 -583,610 -42.10%
Tax Rate - - - - - - - -
Total Cost 62,099 700,108 845,369 852,010 743,480 718,950 583,610 -31.13%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -54.51 -32,645.93 -18,858.71 -1,576.61 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -2.93 -16.40 -20.53 -22.61 -22.90 -32.73 -32.13 -32.88%
EPS Diluted -2.93 -16.40 -20.53 -22.61 -22.90 -32.73 -32.13 -32.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.